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Abstract : 
The pro-inflammatory cytokine interleukin 1β (IL-1β) has been shown to promote 
angiogenesis. It can have a neurotoxic or neuroprotective effect. Here we have studied the 
expression of IL-1β in vivo and the effect of the IL-1 receptor antagonist (IL-1Ra) on 
choroidal neovascularization and retinal degeneration. IL-1β expression significantly 
increased after laser injury (rt-PCR) in C57Bl6 mice, in the C57Bl6 Cx3cr1-/- model of age-
related macular degeneration (ELISA) and in albino Wistar rats and albino BALB Cx3cr1+/+ 
and -/- mice (ELISA) after light-injury. IL-1β was localized to Ly6G positive, Iba1 negative 
infiltrating neutrophils in laser-induced CNV as determined by immunohistochemistry. IL-
1Ra treatment significantly inhibited CNV, but did not affect Iba1 positive macrophage 
recruitment to the injury site. IL-1β significantly increased endothelial cell outgrowth in aortic 
ring assay independently of VEGF, suggesting a direct effect of IL-1β on choroidal 
endothelial cell proliferation. Inhibition of IL-1β in light- and laser-induced RD models did 
not alter photoreceptor degeneration in Wistar rats, C57Bl6 mice or retinal degeneration 
prone Cx3cr1-/- mice. Our results suggest that IL-1β inhibition might represent a valuable and 
safe alternative to VEGF inhibition in the control of CNV in the context of concomitant 
photoreceptor degeneration as observed in AMD.  
 
Introduction : 
The IL-1 family of cytokines plays a key role in the initiation of acute inflammatory 
responses 1. Interleukin 1 beta (IL-1β) interacts with IL-1 receptor I (IL-1RI), composed of 
IL-1R and IL-1R accessory protein (IL-1RacP) subunits. IL-1 receptor antagonist (IL-1Ra) 
competes with IL-1β for its binding site 1. IL-1β is a potent inflammatory mediator with 
chemotactic 2 and angiogenic 3, 4 properties. It is a neurotoxic mediator in ischemic brain 
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injury 5 but can attenuate glutamate neurotoxicity in the retina 6 and protect against light-
induced or hereditary photoreceptor degeneration 7, 8. 
Age-related macular degeneration (AMD) is the leading cause of vision loss in elderly people 
in industrialized countries 9. Its most prominent pathological features are photoreceptor 
degeneration and choroidal neovascularization (CNV) 10. In AMD, IL-1β is secreted by RPE 
cells and CD68 positive cells in choroidal neovascular membranes 11 and is therefore a 
possible proangiogenic and neuroprotective or neurotoxic mediator in AMD. 
IL-1Ra is clinically used to treat juvenile idiopathic arthritis 12, it has been shown to inhibit 
neurotoxicity in ischemia in animal models 13. Intravitreal human IL-1Ra injections have been 
shown to efficiently inhibit CNV in a rat model 14. To analyze the possible implication of IL-
1β in CNV and retinal degeneration, we studied the expression of IL-1β in laser-induced 
CNV in mice and in light-induced retinal degeneration in rats and mice. We localized IL-1β 
expression by immunohistochemistry and inhibited IL-1β activity with IL-1Ra 
supplementation. 
 
Materials and Methods 
Animals 
10 week old Wistar rats and C57B6j wild type mice were purchased from the Janvier 
breeding center (Le Genest-St-Isle, France). Cx3cr1-/- C57B6j mice were backcrossed for six 
generations into the BALB/c background (Janvier) to obtain the Cx3cr1-/- BALB/c strain and 
kept in specific pathogen-free conditions with food and water available ad libitum and housed 
in a 12/12 hr light/dark (100-500 lux) cycle. Animal experiments were approved by the 
Institutional Animal Care and Use Committee. 
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Laser coagulation 
10-week-old C57Bl6 mice were anesthetized with an intramuscular injection of ketamine (50 
mg/kg) and xylazine (10 mg/kg). Their pupils were fully dilated with 1% tropicamide. 
Coverslips positioned on the mouse cornea were used as a contact glass. 4 laser coagulations 
were performed 4 to 5 disc diameters away from the papillae with an Argon laser (532 nm) 
mounted on a slit lamp (400 mW, 50 ms and 50 µm). Mice were treated with daily 
subcutaneous injections of PBS or human recombinant IL-1Ra (Kineret, Biovitrum, 
Stockholm, Sweden) at 1mg/d/kg until sacrifice.  
Choroidal flatmounts, Immunohistochemistry and CNV quantifications 
Eyes were enucleated, fixed in 4% PFA for 15 minutes at room temperature and sectioned at 
the limbus; the cornea and lens were discarded (for CNV quantification, mice were perfused 
with fluorescein dextran 106 before enucleation). Retinal and RPE/choroidal flatmounts were 
stained according to previously described standard immunohistochemical procedures 15. The 
primary antibodies and lectins used were Bandeirae simplicifolia lectin (Sigma Aldrich, Saint 
Quentin Fallavier, France),  goat anti-mouse IL-1β (R&D, Lille, France), rabbit polyclonal 
anti-IL-1RI (Santa Cruz, Heildeberg, France), rabbit polyclonal anti-Iba1 (Wako, Neuss, 
Germany),  rat anti-mouse Ly6G (Miltenyi Biotec, Paris, France),  and goat anti-human 
Collagen IV (R&D, Lille, France). The corresponding Alexa secondary antibodies (Molecular 
Probes, Leiden, the Netherlands) were used to reveal the primary antibodies, and flatmounts 
were counterstained with 4-6-diamino-2-phenylindole (DAPI). The choroids and retinas were 
radially incised, flatmounted, and viewed with the same fluorescence microscope. Flatmounts 
were viewed with a fluorescence microscope (DM5500B, Leica, Nanterre, France). All 
immunostaining was repeated at least 3 times, and stains omitting the primary antibody served 
as negative controls. Ly6G positive and Iba1 positive cells were counted on stained whole 
RPE/choroidal flatmounts up to the ciliary body and on the outer segment side of the retina. 
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The surface covered by perfused CNV was measured on photographs of fluorescein dextran 
106 perfused choroidal flatmounts with ImageJ analysis software (surface covered by 
fluorescein staining). The average CNV size was calculated per eye. 
Microvascular Sprouting from Aortic Explants 
Aortae from adult C57BL6 were cut into 1-mm-thick rings and covered with 30 µL of 
Matrigel (BD Biosciences, Le Pont de Claix, France) in 24-well tissue cultures plates. Aortic 
rings were cultured for 3 days in Dulbecco’s Modified Eagle’s Medium (DMEM, Invitrogen, 
Cergy Pontoise, France) containing 10% FCS, 1% penicillin/streptomycin, and 0.2% 
fungizone. Explants were exposed to IL-1β (5ng/mL; R&D system, Lille, France), IL-1Ra 
(10mg/mL) and VEGFR1s (150ng/mL; R&D) from day 3 to day 7 of culture. Photographs of 
individual explants were taken every day and the surface covered by the aortic ring and the 
vascular sprouts was measured daily from day 3 to 7. The surface of each individual aortic 
ring and pre-incubation sprouts at day 3 was subtracted from the surface at day 4 to calculate 
the vascular sprouting that occurred in the presence of the ligands and controls. 
Reverse Transcription and Real Time Polymerase Chain Reaction (RT PCR) 
Total RNA was isolated with NucleoSpin RNA II Kit (Macherey-Nagel, Hoerdt, France). 
Single-stranded cDNA was synthesized from total RNA (pre-treated with DNaseI 
amplification grade) using oligodT as primer and superscript reverse transcriptase (Invitrogen, 
Cergy Pontoise, France). Subsequent real-time polymerase chain reaction (RT-PCR) was 
performed using cDNA, qPCR SuperMix-UDG Platinum SYBR Green (Invitrogen), and the 
following primers (0.5 pmol/µl): mm actin sense: 5’-AAGGCCAACCGTGAAAAGAT-3’; 
mm actin antisense : 5’- GTGGTACGACCAGAGGCATAC-3’; mm IL-1β sense : 5’-
CATGGAATCCGTGTCTTCCT-3’; mm IL-1β antisense : 5’-
GAGCTGTCTGCTCATTCACG-3’; mm VEGF sense : 5’-
GTGAGCCAGGCTGCAGGAAG-3’; mm VEGF antisense : 5’-
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GAATGCGTCTGCCGGAGTCT-3’; rn actin sense : 5’-
AAAGAAAGGGTGTAAAACGCAG-3’; rn actin antisense : 5’-
AAAGACCTCTATGCCAACACAG-3’; rn IL-1β sense : 5’-
GGAACCCGTGTCTTCCTAAA-3’; rn IL-1β antisense : 5’-
CTGACTTGGCAGAGGACAAA-3’ 
PCR reactions were performed in 40 cycles of 15 s at 95°C, 45 s at 60°C. Product was not 
generated in control reactions in which reverse transcriptase was omitted during cDNA 
synthesis. 
Light-Induced Degeneration 
10-week-old rats and 8-week-old Cx3cr1-/- mice were were adapted to darkness for 12h and 
pupils were fully dilated with 1% Atropin (Novartis, Rueil Malmaison, France). Animals 
were then exposed to green LED light (4500 Lux) for 12 hours and subsequently kept in 
cyclic 12h/12h normal animal facility conditions. Control and light-exposed rats and mice 
were treated with daily subcutaneous injections of PBS or IL-1Ra (Kineret, Biovitrum, 
Stockholm, Sweden) at 1mg/d/kg until sacrifice and a volume of 5 (rats) or 2 µL (mice) of IL-
1Ra at 150 mg/mL was injected intravitreally at day 0 and day 3 after illumination. 
Protein Analysis 
Eyes were enucleated, sectioned at the limbus and the cornea and lens were discarded. The 
complex retina/RPE/choroid/sclera was placed in 150 µL PBS 1x supplemented with a 
protease inhibitor cocktail (Calbiochem, Fontenay-sous-Bois, France) followed by 
homogenization with a plastic pestle. The lysate were cleared of debris by centrifugation at 
2000 rcf for 10 minutes at 4°C. Total protein content of supernatant was determined by 
commercial assay (Bradford kit, Eragny-sur-Oise, France). Supernatant IL-1β level was 
determined with a sandwich enzyme-linked immunoabsorbent assay (ELISA), according to 
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the manufacturer’s instructions (R&D Systems, Lille, France) and normalized for total 
protein. 
Histology  
For histology, eyes were fixed in 0.5% glutaraldehyde, 4% PFA PBS for 2 hours, dehydrated 
and mounted in historesin. 5-µm oriented sections, crossing the centre of the laser injury 
(CNV model) or inferior pole, optic nerve and superior pole (light-induced model), were cut 
and stained with toluidin blue. Rows of nuclei in the outer nuclear layer were counted at 
different distances from the injury site (CNV model) or optic nerve (light-induced model). 
Statistical Analysis 
Graph Pad Prism 5 (GraphPad Software) was used for data analysis and graphic 
representation. All values are reported as mean ± SEM. Statistical analysis was performed by 
one-way and two-way analysis of variance followed by post-hoc Bonferroni’s test for 
comparison among means. P < 0.05 was considered statistically significant. 
 
Results 
IL-1β is induced in laser-induced neovascularization and localizes to the injury site. 
IL-1β is known for its proangiogenic properties 3, 4. It is secreted by CD68 positive cells in 
choroidal neovascular membranes in AMD 11. Its inhibition has recently been shown to 
prevent laser-induced subretinal neovascularization in rats, but its induction, expression 
pattern, and impact on inflammation in the laser model has not been analyzed 14, 16. We first 
analyzed IL-1β expression at different time points in laser-induced CNV in the retina (Fig. 
1A) and choroid (Fig. 1B) of C57Bl6 mice. A strong induction of IL-1β mRNA is observed as 
early as 1h in the retina (55fold) and at 6h (35fold) and 20 hours (18fold) in the choroid. To a 
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lesser extent, a tendency for vascular endothelial growth factor (VEGF) mRNA induction was 
detected in the retina at 1h (Fig. 1C) but not in the choroid (Fig. 1D; control n=4, 1h n=8, 6h 
n=7, 20h n=5, 72h n=4 retinas/choroids). To identify IL-1β expressing cells, we performed 
immunohistochemistry of IL-1β (green staining Fig. 1 E, I and M), the neutrophil marker 
Ly6G (Fig. 1 F, J and N) and the monocyte/macrophage marker Iba1 (Fig. 1 G, K and O) on 
choroidal/RPE flatmounts of uninjured control eyes (Fig. 1E-H) and 10h (Fig. 1 I-L) and 72h 
(Fig. 1M-P) after laser impact. Uninjured control eyes did not stain positive for IL-1β, Ly6G 
or Iba1 (Fig. 1 E-H). At 10h after the injury small IL-1β positive cells are visible at the site of 
impact (Fig 1I) (n=4 eyes). Triple labeling at 10h using the neutrophil marker Ly6G (red 
fluorescence Fig.1J) and the monocyte/macrophage marker Iba1 (blue fluorescence Fig. 1K), 
reveals that the IL-1β positive cells are Ly6G positive and Iba1 negative (Fig. 1L merge). The 
vast majority of detected IL-1β positive cells were Ly6G positive. 72 hours after the impact 
IL-1β (Fig. 1M) and Ly6G (Fig. 1N) was faint and diffuse, while numerous Iba1 positive cells 
were detected at the injury site (blue staining Fig.1 O, P merge). Immunohistochemistry at 
10h and 72h omitting the primary antibodies resulted in no staining (data not shown) (n=4 
eyes per time point).  
IL-1Ra inhibits choroidal neovascularization independently of macrophage recruitment. 
To evaluate the impact of IL-1β induction on CNV we treated one group of experimental 
animals with subcutaneous saline injections (n=4 mice) and one group with subcutaneous 
injections of 1mg/kg/day recombinant human IL-1Ra (n=5 mice). At day 14 after laser injury 
the CNV was visualized on isolectin-stained (red staining), fluorescein dextran perfused 
(green/yellow staining) RPE/choroidal flatmounts of saline (Fig. 2A) and Il-1Ra treated mice 
(Fig. 2B). Mature, perfused CNV (presenting a tubular structure with a lumen) was quantified 
as fluorescein positive surface (Fig. 2C). IL-1Ra treated animals showed a 60% reduction in 
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choroidal neovascularization. Initial lesion size at 10h after laser impact, identified by the loss 
of the RPE cell layer, was quantified on choroidal/RPE flatmounts of saline and Il-1Ra treated 
mice and showed no significant difference (Fig. 2D), excluding a possible initial difference of 
the laser injury in the two groups. 
IL-1β has chemotactic properties and can alter macrophage recruitment to the granulomateous 
tissue that forms after injury 2. It might thereby indirectly influence angiogenesis. To test this 
hypothesis, we visualized neutrophils and macrophages/microglial cells 10h (Fig. 2 E and F) 
and 72h (Fig. 2 H and I) after laser injury, on Ly6G (red staining) and Iba1 (green staining) 
stained RPE/choroidal flatmounts of saline (Fig. 2 E and H; n=3 mice) and Il-1Ra treated 
(Fig. 2F and I; n=3 mice) mice. Neutrophil (Fig.2 G) and macrophage/microglial cell (Fig. 2J) 
prevalence were quantified. Ly6G positive neutrophils were significantly recruited to the 
injury site, reaching their maximum at 10h. Neutrophil recruitment was stronger in IL-1Ra 
treated animals (Fig. 2G; n=3-4 mice per time point). IL-1Ra treatment did not alter Iba1 
positive macrophage/microglial cell recruitment, which reached the maximum in both saline 
and IL-1Ra treated groups at 4d (Fig. 2 J). 
IL-1β induces vascular sprouting in aortic rings.  
IL-1β exerts its activity by acting on the IL-1 receptor I (IL-1RI) 1. It induces angiogenesis in 
the cornea in vivo 3, IL6 expression 17, and microparticle release from vascular endothelial 
cells in vitro 18. IL-1RI is expressed on numerous cell types, notably it is constitutively 
expressed on vascular endothelium 17. IL-1RI immunohistochemistry on choroidal/RPE 
flatmounts of C57Bl6 mice 5d after the injury reveals IL-1RI positive staining around the 
lesion site (Fig 3A) (n=3 mice). Double labeling using the vascular endothelial cell marker 
collagen IV (red fluorescence Fig. 3B) shows that IL-1RI is expressed in the vascular 
endothelium surrounding the lesion and in some unidentified cells  (Fig. 3C merge). 
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To test the effect of IL-1β on vascular sprouting we used the aortic ring assay. Photographs at 
4d, 24 hours after ligand incubation, show the vascular sprouting of PBS (Fig. 3D), IL-1β 
(Fig. 3E), IL-1Ra (Fig. 3F), or IL-1β and IL-1Ra incubated aortic rings (Fig. 3G). 
Measurements of the area covered by the vascular sprouts revealed a significant increase of 
growth in IL-1β exposed aortic rings after 24 hours of IL-1β exposure at 4d that was inhibited 
by simultaneous IL-1Ra incubation (Fig. 3H). Vascular sprouting remained significantly 
increased up to 6d (72 hours of ligand exposure) before aortic rings started dying (data not 
shown). Simultaneous incubation of IL-1β with the soluble VEGFR1 did not significantly 
inhibit the effect of IL-1β incubation alone (Fig. 3I). 
IL-1Ra does not affect photoreceptor survival laser and light-induced injury.  
In AMD, CNV develops in the context of photoreceptor degeneration. IL-1β supplementation 
has been shown to inhibit photoreceptor degeneration in rat models of light-induced 
degeneration 7 and protect photoreceptor degeneration observed in Royal College of Surgeons 
rats 8. IL-1β inhibition might have a deleterious effect on retinal degeneration. Laser-injury 
used to induce CNV also induces a local inflammatory reaction and retinal degeneration in the 
vicinity of the laser impact. To evaluate whether IL-1Ra influences the laser-induced 
photoreceptor degeneration, we treated laser-injured C57Bl6 mice with daily subcutaneous 
injections of saline (n=3 mice) or IL-1Ra (n=4 mice) and prepared histological sections 
crossing the lesion site at d14 (Fig. 4A and B respectively). Quantification of rows of nuclei at 
increasing distances from the injury site revealed no difference in photoreceptor cell loss in 
the vicinity of the laser impact (Fig. 3C). 
To analyze the effect of IL-1β inhibition in a non-neovascular context, we exposed Wistar rats 
to light-induced retinal degeneration and analyzed IL-1β expression by RT-PCR in eye cups 
(Fig. 4D; control n=4 eyes, 1h n=5 eyes, 12h n=5 eyes). IL-1β transcript was significantly 
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induced (x5) in the eye at 12 hours after the onset of light-induced stress. To evaluate the 
influence of the endogenously-produced IL-1β on photoreceptor survival we injected Wistar 
rats with either PBS (n=4 rats) or IL-1Ra (n=6 rats) (subcutaneously 1mg/kg/day and 
intravitrealy and 5µL of a 150 mg/mL solution at d1 and d3 to ensure penetration of a 
possibly intact blood retinal barrier in the eye). Control animals that were raised under normal 
light conditions revealed no signs of toxicity at this dosage (data not shown). At 7d, histology 
of control (Fig. 4E) light-exposed PBS treated (Fig. 4F) and light-exposed IL-1Ra treated rats 
(Fig. 4G) revealed significant thinning of the outer nuclear layer (ONL) in both groups. 
Quantification of rows of nuclei at different distances from the optic nerve measured from the 
inferior pole to the superior pole revealed no differences in photoreceptor cell loss throughout 
the retina (Fig. 4H). 
IL-1Ra does not affect photoreceptor survival in degeneration prone CX3CR1-/- mice. 
We have previously shown, that the T280M polymorphism of CX3CR1 leads to dysfunctional 
CX3CR1 and is associated with AMD. Furthermore, Cx3cr1-/- mice develop spontaneous 
photoreceptor degeneration by the age of 18 months and exaggerated photoreceptor 
degeneration in light-induced models 19, 20. Here, we analyzed the expression and impact of 
IL-1β in the Cx3cr1-/- model of AMD. First, we analyzed IL-1β expression in C57Bl6 
Cx3cr1+/+ and C57Bl6 Cx3cr1-/- mice at 3 and 18 months of age (Fig. 5A n=4 eyes/group). IL-
1β protein was significantly increased in 18-month-old C57Bl6 Cx3cr1-/- mice compared to 
Cx3cr1+/+ mice. Similarly, 4500lux light-exposed BALB Cx3cr1+/+ and BALB Cx3cr1-/- 
animals revealed a significant increase of IL-1β protein 24h after onset of the light injury 
compared to normal light-raised Cx3cr1+/+ and Cx3cr1-/- mice (Fig. 5B; n=4 eyes/group). 
Interestingly, the basal level of IL-1β expression was more important in young C57BL6 mice 
than in BALB mice. The increase of IL-1β protein levels in light-induced-injury in BALB 
Cx3cr1+/+ and Cx3cr1-/- mice were not different from each other and comparable to 18-month-
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old C57Bl6 Cx3cr1-/- mice. To evaluate if IL-1β plays a role in photoreceptor degeneration in 
the context of CX3CR1 deficiency, we exposed two-month-old BALB Cx3cr1-/- mice before 
significant spontaneous degeneration was observed to light-induced degeneration 19 (Fig. 5C). 
PBS (n=4 mice) or IL-1Ra (n=6 mice) were injected subcutaneously 1mg/kg/day and 
intravitrealy (2µL of a 150 mg/mL solution) at d1 and d3 to ensure penetration of a possibly 
intact blood retinal barrier in the eye. Saline-treated controls (n=6 mice; Fig. 5D) degenerated 
similarly to IL-1Ra treated Cx3cr1-/- mice (Fig. 5E; n=6 mice) and no significant difference 
could be observed throughout the retina (Fig. 5F). Control Cx3cr1-/- animals that were raised 
under normal light conditions and treated with intravitreal and subcutaneous PBS or IL-1Ra 
revealed no signs of toxicity at this dosage (Fig. 5G). 
Discussion 
We demonstrate that IL-1β expression rapidly increases in laser- and light-induced injury. 
The expression in laser-induced injury shows rapid induction that lasts for about two days 
(Fig. 1). Immunohistochemistry at 10h localizes IL-1β mainly to infiltrating neutrophils, as 
demonstrated by a positive Ly6G co-staining (specific for neutrophils and not expressed on 
monocytes 21) and negative Iba1 co-staining (specifically expressed on macrophages and 
microglial cells 22) (Fig. 1). The identity of IL-1β expressing cells was further confirmed by 
their multilobulated nuclei (data not shown) and is corroborated by the IL-1β expression 
kinetics that coincide with early neutrophil recruitment in CNV 23. The majority of IL-1β 
expressing cells in our experiments were Ly6G positive neutrophils and the contribution of 
Iba1 positive macrophages/microglia was negligible. Nevertheless, occasional IL-1β staining 
was also detected in RPE cells adjacent to the laser injury. Activated polymorphonuclear 
neutrophils have been shown to express IL-1β 24 and our data shows that these cells are the 
predominant source of IL-1β after laser injury in the mouse. IL-1β is expressed in CD68 
positive cells in human neovascular membranes which were interpreted to be macrophages 11. 
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Although macrophages can express CD68, it has recently been shown that the main CD68 
expressing cells in the injured central nervous system are neutrophils 25. It is possible that 
neutrophils participate in IL-1β in AMD. Studies using more specific markers of neutrophils 
and macrophages are needed to determine the cell types expressing IL-1β in the human 
disease. 
IL-1β inhibition by recombinant IL-1Ra significantly reduced the development of subretinal 
neovascularization in the mouse model of laser-induced subretinal neovascularization (Fig. 2). 
Our results corroborate an earlier report that IL-1Ra inhibits neovascularization in a rat model 
14, 16.  
Neutrophils and macrophages promote CNV 23, 26-28; IL-1Ra has been shown to inhibit 
macrophage recruitment to the atherosclerotic plaque in a mouse model 2. We therefore tested 
the influence of IL-1Ra treatment on neutrophil and macrophage recruitment to the laser-
injury site as a possible mechanism of CNV inhibition (Fig. 2). Interestingly, IL-1Ra 
treatment significantly increased the number of Ly6G positive neutrophils at 10h, suggesting 
a possible IL-1β dependent negative feedback in neutrophil recruitment. No inhibition of 
macrophage/microglial cell recruitment was observed in IL-1Ra treated mice after laser 
injury. Therefore IL-1Ra-dependent inhibition of CNV is unlikely to be mediated by an 
inhibitory effect on the macrophage recruitment.  
IL-1β exerts its activity by acting on the IL-1 receptor I (IL-1RI) 1. Vascular endothelium, 
which constitutively expresses IL-1RI 17, releases IL6 17 and microparticles 18 upon IL-1β 
stimulation. We show that collagen IV expressing vascular endothelial cells in CNV express 
IL-1RI in vivo (Fig. 3). To evaluate a direct effect of IL-1β on vascular sprouting 
independently of inflammatory recruitment, we submitted aortic rings to IL-1β in vitro (Fig. 
3). We show that IL-1β significantly induces vascular sprouting of aortic rings after 24 hours 
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of IL-1β exposure. This difference was maintained for up to 72 hours of IL-1β incubation. A 
previous study has shown an inhibitory effect of IL-1β on vascular sprouting in the aortic ring 
assay at ten days 29. In our study, aortic rings became unviable after 7 days in culture and we 
could therefore not corroborate or contradict these findings. IL-1β has been suggested to 
induce angiogenesis via a sustained VEGF induction in fibroblasts 30. In our in vivo 
experiments we did not detect a sustained VEGF induction following the IL-1β induction in 
laser-injured eyes. Furthermore, vascular sprouting of aortic rings simultaneously incubated 
with IL-1β and the soluble VEGFR1 did not differ from rings incubated only with IL-1β, 
suggesting that the proangiogenic effect is independent of VEGF. Previous studies have 
shown that IL-1β directly induces IL-6 17 and microparticles release from the vascular 
endothelium 31 and that IL-1β inhibitor CK112 and CK116 inhibit HUVEC cell proliferation 
16. The proangiogenic effect of IL-1β we observed in vivo and in vitro might therefore be a 
direct effect of endothelial cell proliferation.  
In AMD, subretinal neovascularization occurs simultaneously with retinal degeneration. To 
make anti-IL-1β therapy a viable option, the influence of IL-1β on photoreceptors has to be 
evaluated in vivo. Previous reports have shown that IL-1β develops neurotoxic properties in 
the brain 5, 13, 32. However in the retina IL-1β was shown to inhibit ganglion cell death 6 and 
IL-1β substitution saved photoreceptors in light-induced models 7 and genetic retinal 
degeneration 8. Here we show that IL-1β is significantly induced in the light-induced model in 
albino rats (Fig. 4D) and in albino mice (Fig. 5B). To test the effect of IL-1β inhibition on 
retinal degeneration, we treated the laser-injured C57Bl6 mice and light-exposed rats with IL-
1Ra at dosages that were sufficient to significantly inhibit CNV in mice (see above) and rats 
14. Interestingly, IL-1Ra at a dose that significantly inhibits CNV does not exacerbate 
photoreceptor degeneration in vivo (Fig. 4).  
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We have previously shown that a dysfunctional CX3CR1 is associated with AMD. Cx3cr1-/- 
mice develop spontaneous subretinal macrophage accumulation that is associated with 
photoreceptor degeneration by the age of 18 months 19. Similarly, these mice develop 
exaggerated photoreceptor degeneration in light-induced models 20. We analyzed the 
expression and impact of IL-1β in the Cx3cr1-/- model of AMD. IL-1β significantly increases 
with age in Cx3cr1-/- animals. This increase coincides with the observed subretinal 
inflammation in these animals 19 and might reflect IL-1β produced by subretinal inflammatory 
cells. In light-induced injury BALB Cx3cr1+/+ and Cx3cr1-/- mice, IL-1β was rapidly induced, 
similar to the rat and to laser-induced CNV. As shown in the mouse CNV model and rat 
models (Fig. 4), IL-1Ra substitution in control and light-exposed Cx3cr1-/- mice in dosages 
sufficient to significantly inhibit CNV had no deleterious effect on photoreceptor survival 
(Fig. 5). Although exogenous IL-1β substitution has been shown to protect photoreceptor 
degeneration in a light-induced model 7, its inhibition does not exacerbate degeneration in 
wild type mice (CNV model) or light-exposed rats, nor in degeneration-prone Cx3cr1-/- mice. 
The apparent contradiction of IL-1β mediated photoreceptor protection and the absence of an 
exacerbating effect of IL-1Ra might be explained by different IL-1β concentrations. While the 
neuroprotective effect of LaVail et al. 7 and Whiteley et al. 8 are found at concentrations of 
0,5-5µg of IL-1β per eye, the maximum IL-1β concentration we measured with age- and 
light-induced injury correspond to approximately 50 pg/eye. The endogeneously-produced 
amount of IL-1β might therefore be well below neuroprotective concentrations and therefore 
have no effect on photoreceptor survival. 
In summary, IL-1β is induced by laser- and light-induced injury. We confirm that IL-1Ra 
substitution efficiently inhibits the development of CNV in the mouse and show that it has no 
deleterious effect on photoreceptor survival. Taken together, our data suggests that IL-1Ra is 
a safe alternative for the treatment of neovascular AMD. 
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Figure Legends: 
Fig.1 : IL-1β expression in laser-induced neovascularization. 
IL-1β rtPCR in retina (A) and choroid (B) and VEGF rtPCR in retina (C) and choroid (D) at 
different time points in laser-induced CNV in the eye cup of C57Bl6 mice (control n=4 eyes, 
1h n=8 eyes, 6h n=7 eyes, 20h n=5 eyes, 72h n=4 eyes; one way Anova * p=0,03 for A and 
B). Representative micrographs of immunohistochemistry of uninjured (E-H), 10h (I-L), and 
72h (M-P) laser-injured choroid/RPE flatmounts (n=4 mice per time point). IL-1β staining 
(green staining E, I and M), Ly6G staining (red staining F, J and N), Iba1 staining (blue 
stainig G, K and O) merged photographs (H, L and P). Scale bar E to P = 50µm. arrow heads: 
Iba1 positive cells. 
Fig.2: IL-1Ra inhibits choroidal neovascularization independently of macrophage 
recruitment. 
Photographs of isolectin (red) stained and fluorescein dextran perfused (green) RPE/choroidal 
flatmounts of PBS treated (A; n=4) and Il-1Ra treated (B; n=5) C57Bl6 mice 14 days after 
laser injury. Quantification of fluorescein positive area (C; Mann Whitney *p < 0.0001). 
Quantification of RPE lesion size of PBS (n=4 mice) and Il-1Ra (n=4 mice) treated mice at 
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10h after laser-impact (D). Representative photographs of Ly6G (red) and Iba1 (green) 
stained RPE/choroidal flatmounts of the border of the injured area of saline (E and H; n=3 
mice/group) and Il-1Ra treated (F and I; n=3mice/group) mice 10h (E and F) and 72h (H and 
I) after laser injury. Quantification of Ly6G (G) and Iba1 (J) positive cells / impact at 
different time points (F; Mann Whitney *p= 0,14). Scale bar A, B, E, F, H and I = 50µm 
Fig. 3: IL-1β induces vascular sprouting in aortic rings 
Confocal microscopy image of IL-1RI (green staining A) and Collagen IV 
immunohistochemistry (red staining B, merge C) of the laser-injury site at d5 (n=3 mice) of 
C57Bl6 mice. Photographs of aortic rings at day 4, 24 hours after incubation with control (D), 
IL-1β (E), IL-1Ra (F) or IL-1β and IL-1Ra (G). (H) Measurements of the area of vascular 
sprouting in the presence of control (n=6), IL-1β (n=12), IL-1Ra (n=6) or IL-1β and IL-1Ra 
(n=6). (I) Measurements of the area of vascular sprouting in the presence of control (n=6), IL-
1β (n=12), soluble VEGFR1 (n=5) (VEGFR1s) or IL-1β and VEGFR1s (n=6). *p < 0.05 one 
way Anova. Scale bar: A-C = 50µm; D-G = 350µm 
Fig. 4: IL-1 and light and laser-induced injury 
Histology of the photoreceptor cell layer at 100µm of the laser injury in PBS (A n=3 mice) 
and IL-1Ra (B n=4 mice) treated C57Bl6 mice. Quantification of number of rows of 
photoreceptor nuclei at increasing distance from the injury site in PBS and IL-1Ra treated 
animals (C). rtPCR of IL-1β expression in Wistar eye cup mRNA extracts (D; control n=4, 1h 
n=5, 12h n=5). Normal light-raised Wistar rats (E); light injured PBS treated (F; n=4) and 
light-injured IL-1Ra treated (G; n=6) eyes. Quantification of number of rows of photoreceptor 
nuclei at different distances from the optic nerve measured on oriented sections, crossing the 
inferior pole, optic nerve and superior pole (H). Scale bar : A, B = 50µm, E-G= 20µm. ONL: 
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outer nuclear layer; INL: inner nuclear layer; RPE: retinal pigment epithelium; CHO: 
Choroid. 
Fig.5: IL-1β and Cx3cr1-/- AMD model and light-induced injury Cx3cr1-/-mice 
IL-1β Elisa of eye cups of 3 and 18 month old C57Bl6 Cx3cr1+/+ and C57Bl6 Cx3cr1-/- 
animals (A; n=5 to 6). IL-1β Elisa of eye cups of control and light exposed 8 week old BALB 
Cx3cr1+/+ (wildtype) and BALB Cx3cr1-/- eye cups (B; n=4 eyes per group). Normal light 
raised BALB Cx3cr1-/- (C); light-injured PBS treated BALB Cx3cr1-/- (D; n=4) and light-
injured IL-1Ra treated BALB Cx3cr1-/- (E; n=6) eyes. Quantification of number of rows of 
photoreceptor nuclei at different distances from the optic nerve on oriented sections of PBS 
and IL-1Ra treated light-injured 2 months old BALB Cx3cr1-/- mice (F). Quantification of 
number of rows of photoreceptor nuclei at different distances from the optic nerve on oriented 
sections of PBS and IL-1Ra treated control BALB Cx3cr1-/- mice (G). Scale bar = 25µm. 
ONL: outer nuclear layer; INL: inner nuclear layer; RPE: retinal pigment epithelium; RGC: 
retinal ganglion cells. 
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